Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Nymox Pharmaceutical Corporation (NASDAQ: NYMX)

 
NYMX Technical Analysis
5
As on 9th Jun 2023 NYMX SHARE Price closed @ 0.39 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.85 & Strong Sell for SHORT-TERM with Stoploss of 1.47 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NYMXSHARE Price

Open 0.40 Change Price %
High 0.40 1 Day -0.01 -2.50
Low 0.39 1 Week -0.03 -7.14
Close 0.39 1 Month -0.08 -17.02
Volume 33400 1 Year -0.69 -63.89
52 Week High 2.00 | 52 Week Low 0.22
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
NYMX
Daily Charts		 NYMX
Intraday Charts		 Whats New @
Bazaartrend		 NYMX
Free Analysis
 
NYMX Important Levels Intraday
RESISTANCE0.41
RESISTANCE0.40
RESISTANCE0.40
RESISTANCE0.40
SUPPORT0.38
SUPPORT0.38
SUPPORT0.38
SUPPORT0.37
 
NYMX Forecast April 2024
Share
4th UP Forecast1.37
3rd UP Forecast1.06
2nd UP Forecast0.86
1st UP Forecast0.67
1st DOWN Forecast0.11
2nd DOWN Forecast-0.08
3rd DOWN Forecast-0.28
4th DOWN Forecast-0.59
 
NYMX Weekly Forecast
4th UP Forecast1.60
3rd UP Forecast1.21
2nd UP Forecast0.97
1st UP Forecast0.73
1st DOWN Forecast0.05
2nd DOWN Forecast-0.19
3rd DOWN Forecast-0.43
4th DOWN Forecast-0.82
 
NYMX Forecast2024
4th UP Forecast4.07
3rd UP Forecast2.89
2nd UP Forecast2.16
1st UP Forecast1.43
1st DOWN Forecast-0.65
2nd DOWN Forecast-1.38
3rd DOWN Forecast-2.11
4th DOWN Forecast-3.29
 
 
NYMX Other Details
Segment EQ
Market Capital 149878480.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NYMX Address
NYMX
 
NYMX Latest News
 
Your Comments and Response on Nymox Pharmaceutical Corporation
 
NYMX Business Profile
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert test strips that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, The Bahamas. Address: Bay & Deveaux Streets, Nassau, Bahamas
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service